307
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

, , , , , , , , , , , , , , & , MD PhD show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Giuseppe Bronte, Giovanni Sortino, Francesco Passiglia, Sergio Rizzo, Francesca Lo Vullo, Antonio Galvano, Viviana Bazan, Christian Rolfo & Antonio Russo. (2015) Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario. Expert Opinion on Biological Therapy 15:1, pages 45-59.
Read now

Articles from other publishers (5)

Henrique Spaulonci Silveira, Luiz Antonio Lupi, Graziela Gorete Romagnoli, Ramon Kaneno, Iseu da Silva Nunes, Wagner José Fávaro & Luiz Gustavo de Almeida Chuffa. (2020) P-MAPA activates TLR2 and TLR4 signaling while its combination with IL-12 stimulates CD4+ and CD8+ effector T cells in ovarian cancer. Life Sciences 254, pages 117786.
Crossref
Luiz Antonio Lupi, Flávia Karina Delella, Maira Smaniotto Cucielo, Graziela Gorete Romagnoli, Ramon Kaneno, Iseu da Silva Nunes, Raquel Fantin Domeniconi, Marcelo Martinez, Francisco Eduardo Martinez, Wagner José Fávaro & Luiz Gustavo de Almeida Chuffa. (2019) P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study. Molecules 25:1, pages 5.
Crossref
Yanming Sun, Zhitao Yao, Zhihua Zhao, Haifeng Xiao, Xia Mengting, Zhu Xiaojun, Jiang Xuelu & Chuntao Sun. (2018) Natural killer cells inhibit metastasis of ovarian carcinoma cells and show therapeutic effects in a murine model of ovarian cancer. Experimental and Therapeutic Medicine.
Crossref
Xinxin Zhu & Jinghe Lang. (2017) Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer. Journal of Gynecologic Oncology 28:5.
Crossref
E. Delarue, I. Rohr & J. Sehouli. (2014) Empfehlungen für die Behandlung eines OvarialkarzinomrezidivsTherapie strategies for the recurrence of ovarian cancer. Der Onkologe 20:7, pages 674-678.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.